Linking To And Embedding Metabolic Mind’s “Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health”

Today, I review, link to, and embed Metabolic Mind‘s Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health.

All that follows is from the above resource.


Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health 

Are GLP-1 medications like Ozempic, Wegovy, and Mounjaro the future of metabolic health, or just a temporary fix? Dr. Bret Scher breaks down the reality behind the hype and highlights a new policy brief from the Coalition for Metabolic Health that urges clinicians and policymakers to take a more thoughtful, long-term view of how these drugs are used. With 1 in 8 U.S. adults now prescribed GLP-1s, it’s vital to look beyond short-term weight loss. These medications don’t “cure” insulin resistance, preserve lean muscle, or offer clear off-ramps for discontinuation. They can help, but they’re not the whole solution. In this video, Dr. Scher covers:

  • What GLP‑1 medications do (and don’t) do for metabolic health
  • Why lifestyle interventions still matter, especially after stopping medication
  • The role of low‑carb and ketogenic diets in improving insulin resistance
  • How to integrate medications into a sustainable, long‑term health plan

GLP‑1s can be powerful tools for the right patients, but they shouldn’t be the only strategy. This is a conversation about thinking beyond the prescription pad and prioritizing durable metabolic resilience over short‑term results. 📖 Download the full CMH policy brief at https://coalitionformetabolichealth.o… 👉 Subscribe to Metabolic Mind for more evidence-based conversations on mental & metabolic health. #MetabolicMind #MetabolicHealth #GLP1 #FoodAsMedicine 🔎 Have questions about how to apply metabolic therapies effectively? Submit them at https://metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode. Expert Featured:

Resources Mentioned: Coalition for Metabolic Health Policy Brief: GLP-1 Medications

CMH GLP-1 Task Force: Mariela Glandt, MD

Tro Kalayjian, DO

Caroline G. P. Roberts, MD

Mark Cucuzzella, MD FAAFP

Free CME Clinician Trainings: Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon. Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-cli…

 

This entry was posted in GLP-1 Agonists, GLP-1 Receptor Agonists, Metabolic Mind, Metabolic Mind CME. Bookmark the permalink.